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Abstract 
 
Background and purpose 
Aging of the healthy brain is characterized by focal or non-focal white matter (WM) signal 
abnormality (SA) changes, which are typically detected as leukoaraiosis (LA). Hypertension 
is a risk factor for WM lesion formation. This study investigated whether LA might be 
associated with increased CSF pulsatility linked to arterial hypertension.  
 
Methods 
101 individuals without neurologic diseases (53 females and 48 males) aged between 18-75 
years underwent 3T brain MRI with cine phase contrast imaging for CSF flow estimation, 
after providing their informed consent. LA was defined as the presence of focal T2 WM SA 
changes and/or non-focal uniform areas of signal increase termed dirty-appearing-white-
matter (DAWM). Relevant information relating to cardiovascular risk factors was also 
collected.  
 
Results  
When controlled for age and hypertension, significant partial correlations were observed 
between: DAWM volume and: net negative flow (r=-0.294, p=0.014); net positive flow (NPF) 
(r=0.406, p=0.001); and peak positive velocity (r=0.342, p=0.004). Multiple linear regression 
analysis revealed DAWM volume to be significantly correlated with CSF NPF (p=0.019) and 
hypertension (p=0.007), whereas T2 WM SA volume was only significantly correlated with 
age (p=0.002). Combined DAWM and T2 WM SA volumes were significantly related with age 
(p=0.001) and CSF peak negative velocity (p=0.041).  
 
Conclusions  
Rarefaction of WM leading to LA is a multifactorial process, in which formation of DAWM 
induced by hypertension and increased aqueductal CSF pulsatility, may play a contributory 
role. These two factors appear to act independently of each other in a process that is 
independent of age. 
 
 
Introduction  
Aging of the brain in healthy individuals is characterized by atrophy and focal or non-focal 
white matter (WM) signal abnormality (SA) changes, which are typically detected as 
leukoaraiosis (LA).1 However, much remains unknown about the pathophysiology underlying 
these changes. WM SA changes of presumed vascular origin are a common finding in brain 
MRI of older individuals and contribute to cognitive and functional decline.2 Although WM 
degeneration is characterized pathologically by demyelination, axonal loss, and rarefaction 
(processes often attributed to ischemia),3 it is not known precisely how WM SA changes 
form.4 A recent study, investigating the intensity patterns and morphological features of 
periventricular WM SA changes, found hyperintensity intensity levels, distribution, and 
association with risk factors and disease, to be indicative of true tissue abnormalities in old 
age, and something that should not be dismissed as artifacts.4 In particular, the role of dirty 
appearing white matter (DAWM) (sometimes termed ‘diffusely abnormal white matter’) 
formation in the periventricular region is poorly understood.5 DAWM (Figure 1) is defined as a 
non-focal, uniform region of intermediate signal intensity between that of focal T2 WM SA 
changes and that of normal-appearing WM. Image-pathology correlation studies reveal that 
non-focal DAWM changes, compared with focal T2 WM SA changes, are associated with 
mild blood-brain barrier breakdown and myelin loss.6 Therefore, it is thought that non-focal 
DAWM may represent an early stage of WM pathology,6 which is followed at a later stage by 
focal T2 WM SA formation.7,8 
 
Recently we undertook a study involving multiple sclerosis (MS) patients,9 in which we found 
WM lesion formation to be associated with increased cerebrospinal fluid (CSF) pulsatility in 
the aqueduct of Sylvius (AoS). Follow-up work involving healthy subjects linked increased 
aqueductal pulsatility with biomechanical changes in the intracranial space associated with 
altered cerebral venous hemodynamics.10 In addition, we found heart disease, overweight 
and smoking to be associated with increased prevalence of extracranial venous 
abnormalities,11 suggesting that cardiovascular risk factors might also influence pulsatility 
within the intracranial space. 
 
It has been postulated that the presence of cardiovascular comorbidities, in particular arterial 
hypertension (a known risk factor for WM SA formation)12 might be linked to increased CSF 
pulsatility.13 Hypertension is associated with reduced vascular compliance,14 particularly in 
smaller arterial vessels.15 This tends to promote increased pulsatility in the cerebral vascular 
bed,16,17 something that is thought to cause endothelial damage and lumenal change.14 
Increased cerebral blood flow pulsatility has been found to be associated with microstructural 
changes in the WM.16,18,19 Therefore, given that increased CSF pulsatility in the AoS is 
thought to be associated with greater pulsation in the cerebral vascular bed,20 it can be 
postulated that increased aqueductal CSF pulsatility might also be associated with DAWM 
formation. 
 
We therefore hypothesized that DAWM formation and WM SA changes in the brain might be 
associated with increased aqueductal CSF pulsatility linked to arterial hypertension. In order 
to test this hypothesis, we undertook a study involving 101 individuals without neurologic 
diseases with the aim of establishing whether or not WM SA changes, and in particular the 
presence of DAWM, are associated with increased aqueductal pulsatility linked to 
cardiovascular comorbidities. 
 
 
Methods 
 
Patient population 
This study utilized data from an ongoing prospective study of genetic and environmental risk 
factors in individuals with and without neurologic diseases that enrolled over 1,100 
subjects.21,22 One hundred and one consecutive individuals without neurologic diseases (53 
females and 48 males) aged between 18 to 75 years who underwent magnetic resonance 
imaging (MRI) scan with cine phase contrast imaging for CSF flow estimation were included. 
The individuals needed to qualify on a health screening questionnaire containing information 
about medical history (illnesses, surgeries, medications, etc.) and meet the health screen 
requirements for MRI on physical examination, as previously described.22,23,24 Exclusion 
criteria were: pre-existing medical conditions known to be associated with brain pathology 
(e.g. cerebrovascular disease, positive history of alcohol abuse, etc.), history of cerebral 
congenital vascular malformations, or pregnancy. Relevant information relating to 
cardiovascular risk factors [body mass index (BMI), hypertension, hypercholesterolemia, 
heart disease, diabetes and smoking] was collected.  
 
All participants underwent clinical and MRI examinations. The study was approved by the 
University of Buffalo Institutional Review Board and written informed consent was obtained 
from all subjects. 
 
MRI acquisition and analysis 
The subject’s brains were examined on a 3 Tesla GE Signa Excite HD 12.0 Twin Speed 
scanner (General Electric, Milwaukee, WI). All sequences were run on an 8-channel head 
and neck (HDNV) coil.  All analyses were performed in a blinded manner.  
 
Brain MRI sequences included 3D T1-weighted imaging (WI) using a fast spoiled gradient 
echo (FSPGR) with magnetization-prepared inversion recovery (IR) pulse for segmentation; 
cine phase contrast imaging for CSF flow estimation; multi-planar dual fast spin-echo proton 
density (PD) and T2-WI; and fluid attenuated inversion recovery (FLAIR) for lesion analysis.  
A sagittal T2-weighted fast SE sequence was also acquired as a localizer for the cine phase 
contrast (PC) prescription, as previously described, with the cine PC sequence prescribed as 
an oblique axial slice through the AoS.9 
 
Pulse sequence characteristics for 3T MRI were as follows: all scans were acquired with a 
256 x 256 matrix and a 25.6 cm FOV for an in-plane resolution of 1 x 1 mm2 with a phase 
FOV of 75% and one average.  Sequence-specific parameters were as follows: for 3D 
HIRES, T1-WI were Echo Time/Inversion Time/Repetition Time TE/TI/TR=2.8/900/5.9 ms, 
Flip Angle (FA)=10°, and 1mm3 isotropic voxels; for the PD/T2: 3-mm-thick slices with no 
gap, TE1/TE2/TR = 12/95/3000 ms, ETL = 14, and for the FLAIR scans, 3-mm-thick slices 
with no gap, TE/TI/TR=120/2100/8500 ms.  
 
CSF flow quantification was performed using a single slice cine phase-contrast velocity-
encoded pulse-gated gradient echo sequence (cine PC) with an TE/TR of 7.9/40 ms, a slice 
thickness of 4 mm, a velocity encoding of 20 cm/s and 32 phases acquired corresponding to 
the cardiac cycle. All subjects underwent the MRI exam during the same time of day (in the 
afternoon hours) to control for circadian variation. The cine PC sequence was acquired with 
a resolution of 0.39 x 0.39 x 4 mm3, with the AoS in the center of the FOV, such that the wrap 
around artifact was present in the edges of the FOV, but did not overlap with the desired 
region of interest (ROI). 
 
Cine phase contrast image analysis 
The net positive and net negative flows (NPF and NNF), together with the net flow (NF = 
NNF + NPF) and the peak positive and negative velocities (PPV and PNV) were calculated 
using a validated methodology as previously described.9 The CSF flow data was processed 
using GE ReportCard software (version 3.6; General Electric, GE, Milwaukee, WI) and 
positive and negative velocities over all 32 phases were recorded. In order to overcome 
limitations in the ReportCard software an in-house semi-automated minimum area of contour 
change (MACC) program was used to correct the ROIs for each phase, as previously 
described.9 NPF and NNF were calculated using only the phases, which have positive and 
negative velocities, respectively.9 CSF flow measures are presented in microliters per beat 
(µL/beat, 1µL = 1mm3), while CSF velocity measures are presented in cm/s. CSF flow 
direction was calculated based on slice prescription such that flow through the AoS out of the 
slice (during diastole, towards the third ventricle) was given as positive, whereas flow into the 
slice (during systole, towards the fourth ventricle) was negative, as described previously.9 
 
 
Detection of white matter signal abnormality changes: 
LA was defined as the presence of focal T2 WM SA changes and/or non-focal uniform areas 
of signal increase termed DAWM. Each subject's relevant T2/PD images were co-registered 
to the FLAIR using a rigid body (6-degrees-of-freedom) registration.25 The FLAIR image was 
used to outline T2 WM SAs, while the co-registered T2/PD images were used to confirm the 
presence of T2 WM SAs and to check for infratentorial T2 WM SAs, as FLAIR imaging is 
known to be insensitive in this area. The T2 WM SA number and volume (T2 WM-SAV) were 
outlined using a semi-automated edge detection contouring/thresholding technique as 
described previously.26 All T2 WM SAs were divided into individual ROIs ≥3mm in size 
(equivalent to ≥14.1 mm3). The periventricular and deep WM regional localization of T2 WM 
SAs was also determined. 
 
In addition, areas of DAWM were outlined (Figure 1). The DAWM was defined as a uniform, 
non-focal area of signal increase on the FLAIR/T2/PD-weighted sequence at 3T, with a 
subtly increased signal intensity compared with the contralateral signal intensity of normal 
appearing WM but less than that of T2 WM SAs, as previously proposed.27 
 
 
Statistical analysis 
Analysis was undertaken using in-house algorithms written in R (open source statistical 
software) and Matlab (Mathworks, Natick, Mass). A one-way ANOVA was used to analyze 
changes in CSF pulsatility with age, with values of p<0.05 using a two-tailed test considered 
statistically significant.   
 
Correlation (full and partial) matrices (Spearman’s r) were computed to quantify the 
relationships between the variables. Multiple linear regression analysis using the dependent 
variables T2 WM-SAV, DAWM volume, DAWM volume+T2 WM-SAV, T2 periventricular SA 
number (T2 PVL-SAN) and T2 deep WM SA number (T2 DWM-SAN) was also performed. In 
this analysis the independent variables were age, BMI, hypertension, hypercholesterolemia, 
heart disease, diabetes, smoking, NF, NNF, NPF, PPV and PNV. A stepwise approach was 
taken, with variables excluded according to their respective t values. Only significant 
variables with p<0.05 were included in the final regression models. 
 
Values of p<0.05 using a two-tailed test were considered statistically significant after the 
Benjamini-Hochberg28 correction for multiple comparisons was applied. 
 
 
 
 
 
Results 
 
Demographic and clinical characteristics 
Table 1 shows the demographic, clinical and MRI characteristics. Subject average age was 
44.7 years (range: 18 – 75 years), with females comprising 54.5% of the cohort. Recorded 
cardiovascular risk factors were as follows: 8.2% had a history of cardiovascular disease; 
22.8% were smokers; 27.8% had hypertension; 17.0% had hypercholesterolemia; with 6.2% 
having diabetes. The mean BMI was 26.8 kg/m2. With the exception of smoking, no 
significant differences were observed between the male and female subjects. The MRI 
characteristics are also presented in Table 1.  
 
One-way ANOVA of the CSF data grouped according to age (Figure 2), revealed statistical 
differences for NF (p =0.003), NPF (p=0.021) and NPV (p=0.030), suggesting that the values 
of these variables changed with age. 
 
Correlation analysis 
Correlation analysis of the demographic and cardiovascular risk factor variables against the 
MRI variables (Table 2) revealed age to be significantly correlated with NF, PNV, T2 WM-
SAV, DAWM volume and DAWM volume+T2 WM-SAV, while hypertension was significantly 
correlated with T2 WM-SAV, DAWM volume and DAWM volume+T2 WM-SAV, with BMI 
significantly correlated with T2 WM-SAV. 
 
Correlation analysis of the relationships between the MRI variables (Table 3a) revealed 
significant correlations between the CSF variables NNF, NPF, PPV and PNV, and the MRI 
variables T2 WM-SAV, DAWM volume and DAWM volume+T2 WM-SAV. Significant 
observations were also observed between: T2 DWM-SAN and the variables NNF, NPF and 
PPV; and T2 PVL-SAN and NPF. 
 
Partial correlation analysis 
When controlled for age and hypertension, the partial correlation analysis (Table 3b) 
revealed significant correlations between: DAWM volume and NNF, NPF and PPV; DAWM 
volume+T2 WM-SAV and NPF and PPV; and T2 DWM-SAN and NNF, NPF.    
 
Linear regression analysis 
Multiple linear regression analysis was undertaken with T2-SAV, DAWM volume, DAWM 
volume+T2 WM-SAV, T2 PVL-SAN and T2 DWM-SAN as dependent variables. The results 
of this analysis (Table 4) revealed that significant models were only achieved for T2 WM-
SAV, DAWM volume, and the composite variable DAWM volume+T2 WM-SAV. Interestingly, 
there were marked differences between the models for T2 WM-SAV and DAWM volume. For 
the dependent variable T2 WM-SAV, the only significant correlation was age, whereas for 
DAWM volume, hypertension and NPF were significant. The results for the DAWM 
volume+T2 WM-SAV model reflected the composite nature of that variable, with age and 
PNV both being significant.  
 
 
 
Discussion 
 
Our principal finding is that in individuals without neurologic diseases, DAWM formation 
appears to be associated with both hypertension and increased aqueductal CSF pulsatility, 
rather than aging per se. When controlled for age, the partial correlations between DAWM 
volume and the CSF variables, NNF, NPF, PPV and PNV were all significant, with the partial 
correlation between DAWM volume and hypertension approaching significance. This 
suggests that rarefaction of the WM leading to LA is a multifactorial process, in which 
formation of DAWM is influenced by factors other than age. As such, our findings mirror 
those of Jolly et al.19 who found microstructural WM changes to be independent of age and 
associated with increased cerebral blood flow pulsatility and aqueductal CSF pulse volume.  
 
Cerebral WM SA changes frequently occur in healthy ageing and are typically detected as 
LA, a radiological finding that presents as increased signal intensity on T2-weighted MR 
images. WM SA changes are a common finding in brain MRI of older individuals and are 
thought to contribute to cognitive and functional decline.2 While it is not known precisely how 
these WM SA changes form, it has been shown that periventricular WM hyperintensities in 
old age represent true tissue abnormalities.4 WM degeneration is characterized 
pathologically by demyelination, axonal loss, and rarefaction, which are thought to be related 
to ischemia.3 Histological studies have shown LA to be characterized by WM morphological 
changes around the periventricular veins.29,30 In particular, LA is associated with non-
inflammatory collagenosis of the periventricular veins, resulting in thickening of the vessel 
walls and narrowing of the lumen.29 Vascular dementia, closely related to LA, has been 
shown to be associated with alterations in venous pulsation,31 and it has been postulated that 
the thickening of the vein walls in LA may be a protective response against increased 
vascular pulsatility.29 Other subtle changes appear to be associated with increased vascular 
pulsatility. Jolly et al.19 found fractional diffusion anisotropy to be negatively correlated with 
both arterial pulse and pulsatility in deep venous territories. Changes in diffusion anisotropy 
have also been reported in the normal-appearing white matter around LA lesions32 and it is 
thought that these represent early changes in the structural organization of white matter that 
are likely to precede the emergence of LA.19  
 DAWM is poorly understood and appears something of an enigma. Most of the work 
undertaken on DAWM has been done in the context of MS, where it has been shown that 
quantitative MR imaging measures of DAWM lie between those of normal-appearing WM 
and focal WM lesions.33,34 This has led some to suggest that DAWM may represent an early 
stage of WM pathology,6 which is followed at a later stage by focal WM lesion formation. In 
support of this, Chung et al.35 reported that DAWM appears to be converted to T2 WM 
lesions in Alzheimer's disease (AD) patients who experience severe jugular venous reflux. 
Others however, suggest that DAWM is by no means a preceding stage for focal lesion 
formation, but rather a different pathologic phenomenon altogether, arising from secondary 
Wallerian degradation and resulting in extensive axonal and myelin loss.34,36  
 
While the pathology associated with DAWM remains unclear, there appears to be a 
consensus that DAWM reflects an increase in extracellular water within the brain 
parenchymal tissue.33 The apparent diffusion coefficient (ADC) has been shown to be greater 
in DAWM compared with normal-appearing WM in patients with MS,34 indicating the 
presence of microstructural changes in DAWM that permit increased transport of water. 
Laule et al.37 found that the primary abnormality in DAWM was a reduction or perturbation of 
the myelin phospholipids that was associated with a reduction in the myelin water fraction. 
This was accompanied by an increase in the total water content of the DAWM, probably due 
to an influx of water into spaces formerly occupied by the phospholipids and myelin proteins. 
As such, this suggests that profound microstructural changes may occur within DAWM, 
possibly due to lipid abnormalities.38 While DAWM has been studied in MS, it has rarely been 
investigated outside of this context, and so it cannot be assumed that DAWM formation in 
healthy individuals necessarily represents the same pathophysiology as that observed in MS 
patients. Notwithstanding this, given that water has a long T2 value, it is reasonable to 
postulate that DAWM formation might also be associated with increased ADC in healthy 
subjects.  
 
While the specific impact of altered CSF pulsatility on DAWM formation has not previously 
been investigated, a number of studies have linked increased intracranial fluid pulsatility and 
microstructural WM damage.16,18,19 Our finding that DAWM formation is associated with 
hypertension appears to be consistent with those who linked microstructural WM damage 
with increased cerebral blood flow pulsatility.16,18,19 Increased pulsatility is indicative of 
decreased arterial compliance, something that is associated with arteriosclerosis39 and 
hypertension.14 Hypertension is a risk factor for small vessel disease40 and LA,41 and is 
associated with changes in vascular mechanics.14,16 It has been suggested that greater 
vascular pulsatility might cause WM damage by increasing perivascular shear stress and 
inducing demyelination, resulting in microstructural WM changes and contributing to the 
proliferation of LA over time.19 Stiffening of the aorta has been linked to the transmission of 
excessive flow pulsatility into the brain,16,17 something that is associated with WM 
microstructural changes in healthy older individuals.19 Recently, Tarumi et al.17 demonstrated 
that arterial stiffness in aging is positively correlated with cerebral vascular pulsatility, and 
that this in turn is associated with a greater volume of WM hyperintensities. Excessive 
intracranial cardiac-related pulsatility (cerebral arterial and CSF) has also been associated 
with brain atrophy among elderly individuals.18 Microstructural changes associated with 
increased cerebral pulsatility may therefore represent early stage alterations in the structural 
organization of the WM, likely to precede the emergence of LA.19 In our linear regression 
model the predictors NPF and hypertension were only able to account for about 20% of the 
variance associated with DAWM formation. This suggests that although both increased 
aqueductal pulsatility and hypertension are associated with DAWM formation, other unknown 
contributory factors must be at work. 
 
The intracranial CSF windkessel mechanism dampens the vascular pulse so that blood flow 
through the cerebral capillary bed is non-pulsatile.42 If however this mechanism becomes 
dysfunctional, then this might lead to increased pulsatility in the AoS, as postulated by 
Greitz,20 who argued that pulsations in the cerebral capillaries were transmitted through the 
parenchyma to the lateral ventricles. If this were the case, then one might expect aqueductal 
pulsatility to be correlated with hypertension. But when we controlled for age, we did not find 
any significant correlations between hypertension and the CSF variables, suggesting that the 
two phenomena are not linked. As such, our finding supports Rashid et al.43 who found in a 
rat study that elevated pulsatile CSF flow in the aqueduct was not matched by an increase in 
microvascular pulsatile flow. Furthermore, our regression analysis model indicated that both 
hypertension and NPF were significant predictors of DAWM formation, suggesting that the 
two mechanisms may be acting independently of each other to produce WM SA changes. 
Increased aqueductal pulsatility has been linked with constricted cerebral venous outflow in 
healthy individuals10 and MS patients,44 suggesting that this phenomenon may be more 
associated with altered compliance in the sub-arachnoid space, rather than pulsatility in the 
cerebral vascular bed. Notwithstanding this, a number of researchers have observed a link 
between the aqueductal pulsatility and subtle changes in the brain parenchyma. Daouk et 
al.45 found ADC, an early indicator of microstructural changes, to be strongly correlated with 
aqueductal stroke volume in AD, and Jolly et al.19 found increased aqueductal CSF pulse 
volume to be associated with microstructural WM changes in elderly subjects. Having said 
this, these correlations appear to be confined microstructural changes, with Jolly et al finding 
no association between CSF pulse volume and LA severity.19    
 
The results regarding T2 WM SA formation appear more ambiguous than those for DAWM 
formation. The regression analysis model for T2 WM-SAV identified age as the only 
significant predictor, while those for T2 PVL-SAN and T2 DWM-SAN revealed no significant 
predictors. However, care should be taken before completely ruling out other contributory 
factors to T2 WM SA formation. This is because the NPF and NF characteristics of the >70 
age group were markedly different to those <70 years of age (Figure 2). When we repeated 
the multiple regression analysis using only those subjects <70 years of age, we found T2 
WM-SAV to be significantly correlated with hypertension rather than age (statistical power = 
80.9%). Also, in the younger cohort, DAWM volume+T2 WM-SAV was significantly correlated 
with hypertension and NPF (statistical power = 99.2%), and DAWM volume was significantly 
correlated with hypertension and NPF (statistical power = 99.7%). This suggests that 
hypertension may be influential in both T2 WM SA and DAWM formation in young and 
middle-aged adults. As a risk factor for both small vessel disease40  and LA,41 it is perhaps 
not surprising that we found hypertension associated with T2 WM-SA and DAWM formation. 
LA is characterized by thickening and hardening of vessel walls.46 This in theory should 
cause blood flow in the cerebral vascular bed to become more pulsatile.16,17 Bateman42 found 
blood flow through the WM to be highly pulsatile in individuals with LA and concluded that 
this would increase endothelial shear stress, and in turn cause WM damage.31 Lumenal 
narrowing associated with LA may also influence cerebral vascular density. LA is associated 
with decreased cerebral blood flow and capillary loss in both the cortex and the normally 
appearing WM.46 This suggests that the condition affects the brain globally and that it is 
associated with chronic ischemia.46 While the physiological mechanisms associated with this 
phenomenon are not understood, recent work by Hall et al.47 has shown that ischemia 
associated with reduced arteriolar perfusion can result in constriction of capillaries by 
adjacent pericytes, rapidly leading to pericyte death and permanent occlusion of the 
capillaries.48 
 
While we found an association between aqueductal CSF pulsatility and microstructural WM 
changes, we did not measure the pulsatility of the cerebral blood flow. We therefore cannot 
assess the contribution that increased pulsatility in the cerebral vascular bed might make 
towards DAWM formation, or indeed, the relationship between vascular pulsatility and CSF 
pulsatility in the AoS.  
 
Although we report an association between increased aqueductal pulsatility and DAWM 
formation in adults without neurologic diseases, previous studies have linked increased 
aqueductal pulsatility with: early stage WM changes19 in elderly individuals; microstructural 
WM changes in AD patients;45 and increased T2 and T1 WM-SAV in MS patients.9 As such 
there appears to be an association between WM damage and aqueductal pulsatility, which is 
independent of age. Therefore, we conclude that rarefaction of WM leading to LA is a 
multifactorial process, in which formation of DAWM induced by hypertension and increased 
aqueductal CSF pulsatility, may play a contributory role.  
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Tables 
 
Table 1. Descriptive statistics of the demographic, cardiovascular risk factors and MRI data.  
 
Variables  
Subjects 
n = 101 
Males  
n = 46 
Females 
n = 55 
Significance 
p value 
Age (years); mean (SD) 44.7 (17.8) 41.8 (16.1) 47.0 (19.0) 0.145 
BMI (kg/m2); mean (SD) 26.8 (5.7) 27.1 (5.0) 26.6 (6.2) 0.257 
Current smokers; n (%) 23 (22.8) 15 (32.6) 8 (14.5) 0.031* 
Diabetes; n (%) 6 (6.2) 2 (4.5) 4 (7.5) 0.541* 
Hypertension; n (%) 20 (27.8) 5 (17.9) 15 (34.1) 0.134* 
Hypercholesterolemia; n (%) 8 (17.0) 2 (12.5) 6 (19.4) 0.553* 
Cardiovascular disease; n (%) 8 (8.2) 4 (8.9) 4 (7.5) 0.809* 
NF (L/beat); mean (SD) -3.33 (7.83) -4.35 (7.84) -2.47 (7.79) 0.392 
NNF (L / beat); mean (SD) -30.16 (18.73) -31.17 (22.79) -29.32 (14.68) 0.631 
NPF (L / beat); mean (SD) 26.83 (18.82) 26.82 (20.32) 26.85 (17.66) 0.675 
 PPV (cm/s); mean (SD) 6.64 (3.01) 6.87 (3.54) 6.44 (2.50) 0.865 
PNV (cm/s); mean (SD) -8.15 (3.26) -8.32 (3.67) -8.00 (2.91) 0.959 
T2 WM-SAV; mean (SD) 350.5 (1492.7) 177.4 (646.1) 495.3 (1931.6) 0.319 
DAWM volume; mean (SD) 903.1 (1113.2) 1037.0 (1355.4) 789.0 (852.0) 0.463 
DAWM+T2 WM-SAV; mean (SD) 1257.1 (2049.9) 1214.4 (1785.2) 1293.5 (2267.2) 0.729 
T2 PVL-SAN; mean (SD) 0.35 (1.25) 0.28 (0.78) 0.40 (1.55) 0.586 
T2 DWM-SAN; mean (SD) 3.93 (8.58) 2.93 (7.92) 4.76 (9.07) 0.146 
 
BMI, body mass index; NF, net flow; NNF, net negative flow; NPF, net positive flow; PPV, peak 
positive velocity; PNV, peak negative velocity; WM-SAV, white matter signal abnormality volume; 
DAWM, dirty appearing white matter; PVL-SAN, periventricular signal abnormality number; DWM-
SAN, deep white matter signal abnormality number. 
 
Volumes are expressed in cubic millimetres. 
p value determined by 2-tailed Mann Whitney U-test unless otherwise stated. 
* p value determined using chi square test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Spearman correlation values (r values) between demographic and cardiovascular 
risk factor and MRI variables (n = 101)  
 
 NF NNF NPF PPV PNV 
T2 WM-
SAV  
DAWM 
volume 
DAWM+T2 
WM-SAV  
T2 PVL-
SAN  
T2 DWM-
SAN  
Age 0.286***^ -0.120 0.250* 0.158 -0.275***^ 0.507***^ 0.353***^ 0.419***^ 0.108 0.145 
BMI 0.203 -0.120 0.217 0.061 -0.141 0.338***^ 0.072 0.134 0.175 0.206 
Smoker -0.123 0.087 -0.113 -0.020 0.036 -0.024 0.071 0.075 0.005 -0.112 
Diabetes 0.057 -0.147 0.182 0.122 -0.080 0.069 0.043 0.044 0.013 -0.029 
Hypertension 0.185 -0.127 0.182 0.260* -0.267* 0.485***^ 0.325***^ 0.353***^ 0.115 0.124 
Hypercholesterolemia 0.234 0.104 0.004 -0.013 -0.083 0.252 0.202 0.236 -0.189 -0.249 
Cardiovascular 
Disease -0.030 -0.101 0.126 0.104 -0.070 -0.025 -0.102 -0.088 -0.116 -0.055 
^ Significant after Benjamini-Hochberg adjustment 
  
*** p  0.005 level (2-tailed). 
  
** p  0.01 level (2-tailed). 
  
* p  0.05 level (2-tailed). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. (a) Spearman correlation values (r values) between MRI white matter signal 
abnormality and cerebrospinal fluid flow variables; and (b) Spearman partial correlations (r 
values), controlling for age and hypertension, between MRI white matter signal abnormality 
and cerebrospinal fluid flow data.  (n = 101)  
 
  NF NNF NPF PPV PNV 
       
(a) T2 WM-SAV 0.201* -0.228*^ 0.285***^ 0.239*^ -0.264**^ 
 DAWM volume 0.183 -0.296***^ 0.377***^ 0.343***^ -0.311***^ 
 DAWM+T2 WM-SAV 0.188 -0.290***^ 0.373***^ 0.338***^ -0.318***^ 
 T2 PVL-SAN 0.187 -0.195 0.234*^ 0.164 -0.160 
 T2 DWM-SAN 0.131 -0.290***^ 0.308***^ 0.242*^ -0.178 
       
(b) T2 WM-SAV 0.065 -0.199 0.198 0.089 -0.004 
 DAWM volume 0.260* -0.294*^ 0.406***^ 0.342***^ -0.268* 
 DAWM+T2 WM-SAV 0.226 -0.275* 0.377***^ 0.309*^ -0.247* 
 T2 PVL-SAN 0.233 -0.157 0.229 0.160 -0.131 
 T2 DWM-SAN 0.107 -0.313**^ 0.309**^ 0.199 -0.063 
 
^ Significant after Benjamini-Hochberg adjustment 
*** p  0.005 level (2-tailed). 
** p  0.01 level (2-tailed). 
* p  0.05 level (2-tailed). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Results of multiple linear regression analyses for all subjects (n = 101). Dependent 
variables were T2 WM-SAV, DAWM volume, DAWM volume+T2 WM-SAV, T2 PVL-SAN and 
T2 DWM-SAN. Independent variables were age, BMI, hypertension, hypercholesterolemia, 
heart disease, diabetes, smoking, NF, NNF, NPF, PPV and PNV. 
 
 Dependent Independent  Unstandardized Unstandardized Standardized     
 Variables  Variables Coefficients Coefficients Coefficients Significance Adjusted Statistical 
  B Std. Error Beta p value r squared power 
        
T2 WM-SAV Constant -773.503 385.881  0.048 0.081 84.8%* 
  Age 25.171 8.032 0.300 0.002   
         
DAWM volume Constant 120.875 220.958  0.586 0.185 99.2%* 
  Hypertension 794.068 284.530 0.310 0.007   
  NPF 15.923 6.610 0.268 0.019   
        
DAWM+T2 WM-SAV Constant -1395.541 620.481  0.027 0.160 97.9%* 
 Age 36.778 10.956 0.321 0.001   
 PNV -124.903 60.399 -0.198 0.041   
        
T2 PVL-SAN ns ns ns ns ns ns na 
        
T2 DWM-SAN ns ns ns ns ns ns na 
 
ns, not significant; na, not applicable  
* Statistical power determined using post-hoc analysis 
Figure Captions 
 
Figure 1. Representation of dirty appearing white matter (DAWM – white arrow) and 
hyperintense T2 lesions (black arrow) in a 65 yrs old male with hypertension but not altered 
cerebrospinal fluid (CSF) pulsatility (upper row left) and in 69 yrs old male with altered CSF 
pulsatility, but no hypertension (upper row right) on fluid attenuated inversion recovery 
(FLAIR) sequence. The bottom row represent subjects without presence of DAWM or T2 
hyperintense lesions in  64 yrs old female (left) and 64 yrs old male (right) who had no 
hypertension  or altered CSF pulsatility. 
 
 
 
  
 
 
Figure 2. The effect of age on CSF NF, NPF and PNV. Error bars represent one standard 
error of the mean. 
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Figure 2. The effect of age on CSF NF, NPF and PNV. Error bars represent one standard 
error of the mean. 
 
